RESUMEN
This article investigates how regional inequalities shape the employment seeking experiences and behaviour of graduates by drawing on the case of Chinese Master's graduates under COVID19. Based on interviews with graduates who chose to work as the 'targeted selected graduates' (TSG) of University A, located in the underdeveloped regions of North-western China, we show how their employment seeking was jointly impacted by three different but inter-related fields, the national economic, higher education, and graduate employment fields. These students were situated in a unique juncture across these fields;while their elite credentials from University A qualified them for these elite TSG programmes, they were disadvantaged by being excluded from TSG recruitments at economically developed regions. Importantly, we highlight that institutionalised cultural capital in the form of academic credentials from elite HEIs does not work in a 'straightforward' manner, but it has to be considered in conjunction with the geo-economic locations of their HEIs. We, therefore, propose the notion of 'geography-mediated institutionalised cultural capital' to capture this significant but under-theorised aspect of the graduate employment scene. This conceptual innovation enlightens the analysis of regional differences in different countries by considering how official or unofficial regional authorities' interventions shape graduate employment.
RESUMEN
Introduction: Mycobacterium mucogenicum belongs to the rapidly growing mycobacteria, and it is a rare conditional pathogen. Although recent studies suggested that the incidence of M. mucogenicum infection was increased worldwide, there are no case reports of M. mucogenicum and Klebsiella pneumoniae pulmonary infection. Case Presentation: A 32-year-old non-smoking male was diagnosed with congenital atrial septal defect and pulmonary arterial hypertension. After cardiac surgery, lung infections were observed in the patient and then rapidly developed acute respiratory distress syndrome. The cefoperazone and sulbactam, vancomycin, ceftazidime, carbapenem, tigecycline, and micafungin were used for the treatment of pulmonary infection but did not affect. Ultimately, M. mucogenicum and K. pneumoniae were identified as pathogens by using next-generation sequencing. The patient was treated successfully with the administration of clarithromycin, linezolid, tigecycline, and ceftazidime-avibactam. The clinical outcome of this patient was favorable without relapse of infection. Conclusions: This case demonstrates that M. mucogenicum pulmonary infection may result in severe outcomes. The next-generation sequencing technology is important for the identification of M. mucogenicum. Additionally, the clinicians and clinical pharmacists should remain awareness in dealing with M. mucogenicum infection to avoid delaying appropriate treatment.